FDA fines Red Cross nearly $9.6 million for blood safety lapses.
FDA fines Red Cross nearly $9.6 million for blood safety lapses. Is this kind of fine realistic? Where does the money go when the FDA receives it?
Wouldn’t losing $9.6 million seem to put the ARC more at risk for safety failures?
It seems a better process would be to shut down areas that were non-compliant until they function safely.
Read the violations here: FDA.gov
Some thoughts from Philly.com
Safety Dog's Blog 